MEET THE EXPERTS: Introducing Prof Christian Gratzke from Albert-Ludwigs-University, Germany who will present at #USANZ26.
Specialty: Uro-oncology (Prostate cancer) and BPH/LUTS
Read @gratzke.bsky.social Profile and Research here: bit.ly/USANZ26MTE
Merry Xmas! The team of Urology, @uni-freiburg.de, would like to thank all our co-workers and cooperation partners for the support in 2024. And to all patients: please go see a Urologist if needed! We are here for you…
Editor's Choice of the Week: The Highest Grade Group Does Not Drive the Risk of Recurrence when Systematic and MRI-targeted Biopsies are Discordant by @vickersbiostats.bsky.social et al in @eururolfocus.bsky.social
Read the full article here: buff.ly/4fS0sv9
#UroSoMe #EditorsChoice
Our first Editor's Choice Article has been chosen by our EiC Alberto Briganti: EAU Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update by Paolo Gontero et al
Read the full article here: buff.ly/3AXFEDi
#UroSky
Difficult to say, costs are always a problem, but I guess interesting avenue to screen drugs if no other option is available. PDOs should in theory not be too expensive - the drugs are…
PDO‘s as promising tool for Drug Screening
Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine Response - European Urology www.europeanurology.com/article/S030...
BTW the preview of articles could be improved, @bsky.app!
Ride on!
Yes please, thank you!
Hello @bsky.app! Feels good to be here:-)
Embarking into Embark - European Speaker Tour with Stephen Freedland. Excellent symposium in #Munich with Markus Graefen, including insights to the world of top athletes with olympic swimmer Thomas Lurz
